Furthermore, a phase I trial of apitopes in Graves’ disease, with epitopes from the TSHR [51•], noted a reduction in both thyroid hormone secretion and anti-TSHR antibodies in 7/10 patients [19••]. The gene discussed is TSHR; the disease is Graves disease.